Medprin

What Medprin does

Medprin (short for "Medical Printing") is a Class III implantable medical device company founded in 2008 and headquartered in Guangzhou, China, with European operations through Medprin Biotech GmbH in Frankfurt am Main, Germany. The company designs, develops, and manufactures absorbable neurosurgical implants, neurovascular intervention devices, regenerative medicine products, and 3D bioprinting technology. Its core franchise centers on dural repair — ReDura™ (electrospun PLA non-woven patch) and NeoDura™ (synthetic-gelatin composite patch) — supported by Recranio™ PEEK-based patient-specific cranio-maxillofacial implants, StypCel™ oxidized regenerated cellulose hemostat, Immiseal™ hydrogel dural sealant, and DrainiSmooth™ hydrogel-coated ventricular drainage catheters. The company has expanded into adjacent device categories including a full neurovascular intervention suite (EasyMax™ sheaths, Easytork™ guidewires, EasyRace™/EsayRadial™ catheters, Easyport™ distal access catheters, Speedpass™/Speedpass88™ aspiration catheters, Speedflate™ balloon catheters, Easycess™ aspiration pump), GlucoTune™ continuous glucose monitoring for diabetes care, Fursight™ ultrasonic surgical scalpel, and LivPrint™ 3D bioprinting technology.

Medprin's business model is built on direct enterprise sales to hospitals and neurosurgical departments combined with an international distributor network, with marketing concentrated in medical congresses (EANS, MEDICA, DGNC, FIME, Arab Health, HOSPITALAR), academic symposia, peer-reviewed publications, and clinical KOL partnerships. The company serves neurosurgery, cranio-maxillofacial surgery, and increasingly neurovascular intervention and diabetes care segments, with stated reach across 100+ countries and cumulative treatment of approximately 1.7 million patients. Revenue is generated through hardware sales of Class III implantable and interventional devices, with quote-based hospital procurement pricing not publicly disclosed.

The company holds 400+ patent applications and 300+ granted patents globally, ranks Top 7 worldwide in 3D bioprinting patents, and has received CE, ISO 13485, and CFDA certifications across its portfolio. Recent strategic activity includes a $19M funding round from FY Investment in September 2024, opening a new corporate headquarters in 2022, and a substantial 2025 product launch wave across neurovascular, CGM, and surgical energy categories.

Name

Medprin

Legal name

Medprin Biotech GmbH

Website

https://medprin.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

101–250 employees

Short description

Medprin develops and manufactures Class III implantable medical devices and 3D bioprinting technology, with a core focus on absorbable neurosurgical implants including dural repair patches, cranial fixation systems, and an expanding neurovascular intervention portfolio serving hospitals in 100+ countries.

Ownership category

akta.pro rank

Product category

Implantable Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts) (HLAHAEAD)

Keywords

• Implantable medical devices
• Neurosurgical implants
• Dural repair patches
• 3D bioprinting
• Neurovascular catheters

Headquarters

HQ city

Guangzhou

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Implantable Medical Devices: Revenue generated from the sale of Class III implantable medical devices, including absorbable durapatch and cranial fixation products. These are high-value medical devices requiring regulatory approval (CE certification, FDA clearance) and sold directly to hospitals through enterprise sales.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Medprin researches, develops, and manufactures Class III implantable medical devices focused on neurosurgical and cranio-maxillofacial applications, including absorbable dural repair patches (ReDura™, NeoDura™), customized cranial repair systems (Recranio™), absorbable hemostats (StypCel™), dural sealants (Immiseal™), and ventricular drainage catheters. The company also produces a neurovascular intervention portfolio (aspiration catheters, guidewires, sheaths, balloon catheters) and a continuous glucose monitoring system (GlucoTune™), underpinned by proprietary additive manufacturing and 3D bioprinting technology (LivPrint™).

Product overview

Medprin offers a diversified portfolio of high-end medical devices spanning neurosurgical closure solutions, neurovascular interventions, diabetes care, and 3D bioprinting. The core neurosurgical portfolio includes ReDura™ and NeoDura™ dural repair patches, Recranio™ cranio-maxillofacial repair system, StypCel™ absorbable hemostat, Immiseal™ dural sealant, and DrainiSmooth™ ventricular drainage catheters. The neurovascular portfolio features EasyMax™ sheaths, Easytork™ guidewires, EasyRace™ and EsayRadial™ catheters, Easyport™ distal access catheters, Speedpass™ and Speedpass88™ aspiration catheters, Speedflate™ balloon catheters, and Easycess™ aspiration pump. Diabetes care is addressed through GlucoTune™ continuous glucose monitoring system. The company also offers Fursight™ ultrasonic surgical scalpel for energy sealing and dissection. LivPrint™ represents the company's entry into 3D bioprinting technology. Products are available in more than 100 countries and have served nearly 1.7 million patients worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• ReDura™: Regenerative Dura Repair Patch - absorbable electrospun PLA non-woven dural substitute for neurosurgical applications.
• NeoDura™
• Recranio™
• StypCel™
• Immiseal™
• DrainiSmooth™
• LivPrint™
• EasyMax™
• Easytork™
• EasyRace™
• Speedpass™
• Speedpass88™
• Speedflate™
• Easycess™
• GlucoTune™
• Fursight™

Products and services

• ReDura™ Regenerative Dura Repair Patch Electrospun PLA non-woven dural substitute providing watertight closure and suturable handling for dural defect repair in neurosurgical procedures; designed for neurosurgeons and hospital neurosurgery departments.
• NeoDura™ Dural Repair Patch Absorbable dural repair patch made of synthetic material and gelatin composite offering anti-adhesion properties and rapid regeneration; intended for neurosurgical dural closure.
• Recranio™ Customized Cranio-Maxillofacial Repair System Customized PEEK-based cranio-maxillofacial repair system for complex cranial reconstruction using 3D-printed personalized implants; intended for cranio-maxillofacial surgeons and reconstructive surgical teams.
• StypCel™ Absorbable Hemostat 100% absorbable non-woven hemostat based on oxidized regenerated cellulose (ORC) providing hemostasis for capillary, venous, and small artery bleeding within 7-14 days; intended for surgical teams across multiple specialties.
• Immiseal™ Dural Sealant System Quick gel-forming hydrogel dural sealant that crosslinks within seconds to provide watertight sealing and complete degradation, preventing cerebrospinal fluid leakage; intended for neurosurgeons performing cranial and spinal procedures.
• DrainiSmooth™ Hydrogel-coated External Ventricular Drainage Catheter Set Hydrogel-coated external ventricular drainage catheter set designed to minimize tissue damage and infection risks for safer CSF drainage; intended for neurosurgery and intensive care units.
• LivPrint™ 3D Bioprinting Technology Globally first 3D bioprinting technology enabling highly active cell printing with multi-section temperature control from print head to printing platform; intended for tissue engineering and regenerative medicine researchers and bioprinting laboratories.
• GlucoTune™ Continuous Glucose Monitoring System Continuous glucose monitoring system with industry-leading accuracy, real-time data display, consensus guidelines management, and digital platform interconnection; intended for diabetes patients and endocrinology care providers.
• Fursight™ Ultrasonic Surgical Scalpel Ultrasonic surgical system with intelligent generator, transducer, and scalpel for energy sealing and dissecting applications; intended for surgical teams in operating rooms.
• EasyMax™ Long Sheath Long sheath for neurovascular access procedures with optimized minimum bending radius for challenging anatomies; intended for interventional neuroradiologists.
• Speedpass™ Aspiration Catheter Aspiration catheter with excellent kink resistance and negative pressure resistance for thrombus aspiration procedures; intended for neurovascular thrombectomy procedures.
• Speedpass88™ Aspiration Catheter Smaller outer diameter aspiration catheter with thinner wall, bigger lumen, and stronger aspiration for improved navigation and vessel safety in distal neurovascular anatomy.
• Speedflate™ Intracranial Balloon Catheter Intracranial balloon catheter for neurovascular interventions including angioplasty and temporary occlusion; intended for interventional neuroradiology teams.
• Easytork™ Guidewire Guidewire with torque control for neurovascular interventions, providing precise navigation and manipulation during procedures; intended for interventional neuroradiologists.
• EasyRace™ Angiographic Catheter Angiographic catheter for neurovascular imaging and diagnostic procedures; intended for interventional neuroradiology and diagnostic angiography teams.
• EsayRadial™ Access Catheter Radial access catheter with support features and soft tip design for neurovascular procedures; intended for interventional neuroradiologists using radial access approaches.
• Easycess™ Aspiration Pump Aspiration pump for neurovascular procedures providing controlled negative pressure for thrombus aspiration; intended for interventional neuroradiology and stroke teams.

Quantifiable outcome

• Nearly 1.7 million patients treated with Medprin products globally
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered minor and core.

• Russian Medical Congress PartnersminorChannel Partner/ Reseller/ Distributor · 1 January 2021Distribution and partnership relationships established at Russian medical congresses for market access in Russia and CIS countries. Partners facilitate regulatory compliance and local market penetration for Medprin medical devices.
• West China HospitalcoreStrategic or Co-development PartnerAcademic and clinical collaboration partnership focused on neurosurgical applications research, clinical case studies, and knowledge exchange in 3D bioprinting technology for dural repair.
• Charlotte Maxeke Johannesburg Academic HospitalcoreStrategic or Co-development PartnerInternational clinical collaboration partnership for neurosurgical research and training, expanding Medprin's presence in African medical market through academic exchange.
• Beijing Tiantan HospitalcoreStrategic or Co-development PartnerStrategic clinical partnership with leading Chinese neurosurgical center for product development, clinical trials, and academic collaboration in cranial fixation and durapatch applications.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Penumbra: Penumbra is a leading neurovascular intervention company with aspiration catheters (Indigo), sheaths, and pumps that directly overlap with Medprin's Speedpass™, EasyMax™, and Easycess™ neurovascular portfolio.
• Integra LifeSciences: Integra is the global leader in dural repair (DuraGen, DuraMatrix, DuraSeal) and a broad neurosurgery/CNS portfolio. Directly comparable to Medprin's ReDura™, NeoDura™, and Immiseal™ in dural closure and the same hospital customer base.
• Baxter International: Baxter's surgical hemostat portfolio (including oxidized regenerated cellulose-based products like Surgicel) directly overlaps with Medprin's StypCel™ absorbable hemostat in the same surgical specialties.
• W. L. Gore & Associates: Gore's medical division sells expanded PTFE-based dural and hernia patches and other implantable devices. Comparable in absorbable/synthetic implant technology and regulated Class III implantable manufacturing.
• B. Braun (Aesculap): Aesculap competes in neurosurgical implants, durapatches, and CMF reconstruction with established global distribution. Highly comparable to Medprin's neurosurgical closure and cranial fixation portfolio.

Others

• Evonik Industries: Evonik supplies bioresorbable polymers and specialty biomaterials (e.g., RESOMER) used in medical implants and 3D bioprinting — adjacent supplier relationship comparable to Medprin's proprietary absorbable biomaterial strategy.

Broad incumbents

• Johnson & Johnson (DePuy Synthes / Ethicon): DePuy Synthes has a leading CMF/cranial reconstruction franchise and Ethicon sells dural sealants and hemostats; both overlap with Medprin's neurosurgery, CMF, and ultrasonic energy device (Fursight™) categories.
• Medtronic: Medtronic's Neurovascular and Cranial & Spinal Technologies divisions compete with both Medprin's neurosurgical closure and neurovascular intervention product lines, offering scale advantages and clinical evidence depth.
• Stryker: Stryker's Neurosurgical and CMF businesses (via acquired Codman, Synaptive, and other assets) overlap with Medprin's dural repair and cranial reconstruction products, while bringing a much broader surgical portfolio.
• Abbott: Abbott's FreeStyle Libre CGM competes with Medprin's GlucoTune™ continuous glucose monitor in diabetes care, representing a new but directly contested category Medprin has entered.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/BiotechGmbh
• YouTubeyoutube.com/@MedprinBiotechGmbH
• Facebookfacebook.com/MedprinBiotechGmbH
• LinkedInlinkedin.com/company/medprinbiotechgmbh
• Instagraminstagram.com/medprin_2008_neurosurgery

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medprin